Results 91 to 100 of about 981,832 (295)

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Medical oncology [PDF]

open access: yesMedical Journal of Australia, 2002
Ward, R. L., Hawkins, N. J.
openaire   +4 more sources

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, Volume 20, Issue 6, Page 1612-1625, June 2026.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Supplementum 274: Abstracts of the Swiss Oncology & Hematology Congress (SOHC)

open access: yesSwiss Medical Weekly, 2023
Swiss Society of Medical Oncology   +2 more
doaj   +1 more source

The acute oncologist’s role in managing patients with cancer and other comorbidities

open access: yes, 2012
Background: An Acute Oncology Service (AOS) is paramount to providing timely and improved pathways of care for patients who are admitted to hospital with cancer-related problems or suspected cancer.
James Price   +16 more
core   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Multidisciplinary Oncology Education Among Postgraduate Trainees: Systematic Review

open access: yesJMIR Medical Education
BackgroundUnderstanding the roles and patient management approaches of the entire oncology team is imperative for effective communication and optimal cancer treatment.
Houman Tahmasebi   +8 more
doaj   +1 more source

Does transdermal fentanyl work in patients with low BMI? Patient‐reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl

open access: yesCancer Medicine, 2019
Background Low body mass index (BMI) is suspected of being associated with low transdermal fentanyl (TDF) blood levels and worse pain relief. Clinical pain data to support this claim are lacking.
Natalie Moryl   +8 more
doaj   +1 more source

Stressing factors and coping strategies used by oncology nurses Factores estresantes y estrategias de coping utilizadas por los enfermeros que actúan en oncología Fatores estressantes e estratégias de coping dos enfermeiros atuantes em oncologia

open access: yesRevista Latino-Americana de Enfermagem, 2008
In the oncology specialty, many factors can result in occupational stress in nursing professionals. As an attempt to controlling this situation, individuals may use coping strategies.
Andrea Bezerra Rodrigues   +1 more
doaj   +1 more source

Geriatric Oncology: Past, Present, Future

open access: yes, 2008
Efforts to integrate geriatric oncology principles in the training of all medical oncologists are ...
Rao, Arati V   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy